Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019). حسب Mingee Choi (15250732)

الموضوعات:

Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. حسب Mingee Choi (15250732)

الموضوعات:

Detailed treatment status of people who received non- pharmacological treatment at first diagnosis. حسب Mingee Choi (15250732)

الموضوعات:

TXNIP loss does not increase chromatin accessibility. حسب Tian-Yeh Lim (14808976)

Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later. حسب Mingee Choi (15250732)

الموضوعات:

K2 treatment increases access of a hydrophobic probe to the bacterial membrane of <i>K</i>. <i>pneumoniae</i>. حسب Estelle Ifrid (10076719)

"…</b> Three chemical analogs of K2 (dT = deoxythymidine, dU = deoxyuridine and 5-EdU = 5-Ethynyl-2’-deoxyuridine) were tested for their ability to increase the membrane accessibility of NPN. K2 was the only compound that increased significantly the accessibility of the outer membrane of <i>K</i>. …"

PTEN KD increases chromatin accessibility. حسب Ahmed H. Ghobashi (12705573)

"…Red dots indicate peaks with significantly increased or decreased accessibility with Log2 FC > |0.5|. …"

Annual incidence of insomnia disorder (ICD-CODE: G47) Bar: rate of insomnia disorder relative to all patients; Line: average number of outpatient visits for patients with insomnia... حسب Mingee Choi (15250732)

الموضوعات:

General information of patient who diagnosis insomnia disorder (N = 518,119). حسب Mingee Choi (15250732)

الموضوعات:

Treatment at first diagnosis of insomnia disorder (%). حسب Mingee Choi (15250732)

الموضوعات:

The table shows the significant and non-significant altered group with different parameters. حسب Ashraf Attia Mahmoud (21262201)

Traits at cellular, leaf, and whole-plant scales which were significantly different [increased (↑) or decreased (↓)] or non-significant between tolerant and sensitive cultivars in the N-deficient treatment. حسب Ranjeeta Adhikari (9905958)

"…<p>Traits at cellular, leaf, and whole-plant scales which were significantly different [increased (↑) or decreased (↓)] or non-significant between tolerant and sensitive cultivars in the N-deficient treatment.…"

LIF knockout reduces increases immune accessibility. حسب Priyan Bhattacharya (11986545)

Significantly Enriched Pathways. حسب Jiyong Zhang (2498740)

الموضوعات:

Treatment with pan-PKC inhibitor Gö-6983 resulted in a non-significant decrease in <i>GRK6</i> promoter activity. حسب Maike Stegen (8578665)

Pathway analysis based on the protein accessions from the significant glycopeptiforms separately for glycation and glycosylation. حسب Yishai Levin (702481)

Accessible data. حسب Neda Mohammadisima (17199999)

SLE decreases risk for hormonal cancers. حسب Deborah K. Johnson (10001156)

Depleted antibody secreting cells did not result in decreased donor specific antibody in non-sensitized animals. حسب Natalie M. Bath (6316517)

"…(A) T (CD3⁺) and (B) B (CD45R⁺) cell flow crossmatch was performed in non-sensitized animals. IgG1⁺ in the T cell flow crossmatch was the only DSA that BLyS^-/- significantly decreased compared to APRIL^-/- (p<0.03). …"

PTEN KD increases chromatin accessibility at EMT genes. حسب Ahmed H. Ghobashi (12705573)